271 related articles for article (PubMed ID: 27578479)
1. Impact of chronic ischemic heart disease on the health care costs of COPD patients - An analysis of German claims data.
Schwarzkopf L; Wacker M; Ertl J; Hapfelmeier J; Larisch K; Leidl R
Respir Med; 2016 Sep; 118():112-118. PubMed ID: 27578479
[TBL] [Abstract][Full Text] [Related]
2. Excess economic burden of comorbidities in COPD: a 15-year population-based study.
Chen W; FitzGerald JM; Sin DD; Sadatsafavi M;
Eur Respir J; 2017 Jul; 50(1):. PubMed ID: 28751416
[TBL] [Abstract][Full Text] [Related]
3. The economic burden of chronic obstructive pulmonary disease (COPD) in a U.S. Medicare population.
Menzin J; Boulanger L; Marton J; Guadagno L; Dastani H; Dirani R; Phillips A; Shah H
Respir Med; 2008 Sep; 102(9):1248-56. PubMed ID: 18620852
[TBL] [Abstract][Full Text] [Related]
4. Burden of chronic obstructive pulmonary disease in Medicare beneficiaries residing in long-term care facilities.
Simoni-Wastila L; Blanchette CM; Qian J; Yang HW; Zhao L; Zuckerman IH; Pak GH; Silver H; Dalal AA
Am J Geriatr Pharmacother; 2009 Oct; 7(5):262-70. PubMed ID: 19948302
[TBL] [Abstract][Full Text] [Related]
5. Estimates of Medication Expenditure for Ischemic Heart Disease Accompanying Chronic Obstructive Pulmonary Disease.
Rysiak E; Prokop I; Zaręba I; Mróz RM
Adv Exp Med Biol; 2018; 1114():49-55. PubMed ID: 29679364
[TBL] [Abstract][Full Text] [Related]
6. The contribution of symptoms and comorbidities to the economic impact of COPD: an analysis of the German COSYCONET cohort.
Wacker ME; Kitzing K; Jörres RA; Leidl R; Schulz H; Karrasch S; Karch A; Koch A; Vogelmeier CF; Holle R
Int J Chron Obstruct Pulmon Dis; 2017; 12():3437-3448. PubMed ID: 29270005
[TBL] [Abstract][Full Text] [Related]
7. Economic burden prior to COPD diagnosis: a matched case-control study in the United States.
Akazawa M; Halpern R; Riedel AA; Stanford RH; Dalal A; Blanchette CM
Respir Med; 2008 Dec; 102(12):1744-52. PubMed ID: 18760581
[TBL] [Abstract][Full Text] [Related]
8. History of Asthma in Patients with Chronic Obstructive Pulmonary Disease. A Comparative Study of Economic Burden.
Sadatsafavi M; Tavakoli H; Kendzerska T; Gershon A; To T; Aaron SD; FitzGerald JM;
Ann Am Thorac Soc; 2016 Feb; 13(2):188-96. PubMed ID: 26599154
[TBL] [Abstract][Full Text] [Related]
9. Chronic obstructive pulmonary disease involves substantial health-care service and social benefit costs.
Jensen MB; Fenger-Grøn M; Fonager K; Omland Ø; Vinding AL; Hansen JG
Dan Med J; 2013 Jan; 60(1):A4557. PubMed ID: 23340185
[TBL] [Abstract][Full Text] [Related]
10. Direct medical costs of COPD--an excess cost approach based on two population-based studies.
Menn P; Heinrich J; Huber RM; Jörres RA; John J; Karrasch S; Peters A; Schulz H; Holle R;
Respir Med; 2012 Apr; 106(4):540-8. PubMed ID: 22100535
[TBL] [Abstract][Full Text] [Related]
11. Direct and indirect costs of COPD progression and its comorbidities in a structured disease management program: results from the LQ-DMP study.
Kirsch F; Schramm A; Schwarzkopf L; Lutter JI; Szentes B; Huber M; Leidl R
Respir Res; 2019 Oct; 20(1):215. PubMed ID: 31601216
[TBL] [Abstract][Full Text] [Related]
12. Health-care utilization and expenditures among patients with comorbid bronchiectasis and chronic obstructive pulmonary disease in US clinical practice.
Seifer FD; Hansen G; Weycker D
Chron Respir Dis; 2019; 16():1479973119839961. PubMed ID: 30961354
[TBL] [Abstract][Full Text] [Related]
13. Direct and indirect costs of COPD and its comorbidities: Results from the German COSYCONET study.
Wacker ME; Jörres RA; Schulz H; Heinrich J; Karrasch S; Karch A; Koch A; Peters A; Leidl R; Vogelmeier C; Holle R;
Respir Med; 2016 Feb; 111():39-46. PubMed ID: 26725462
[TBL] [Abstract][Full Text] [Related]
14. Changes in COPD demographics and costs over 20 years.
Blanchette CM; Dalal AA; Mapel D
J Med Econ; 2012; 15(6):1176-82. PubMed ID: 22812689
[TBL] [Abstract][Full Text] [Related]
15. Asthma and Chronic Obstructive Pulmonary Disease Overlap Syndrome: Doubled Costs Compared with Patients with Asthma Alone.
Gerhardsson de Verdier M; Andersson M; Kern DM; Zhou S; Tunceli O
Value Health; 2015 Sep; 18(6):759-66. PubMed ID: 26409602
[TBL] [Abstract][Full Text] [Related]
16. Economic burden of diagnosed pertussis among individuals with asthma or chronic obstructive pulmonary disease in the USA: an analysis of administrative claims.
Buck PO; Meyers JL; Gordon LD; Parikh R; Kurosky SK; Davis KL
Epidemiol Infect; 2017 Jul; 145(10):2109-2121. PubMed ID: 28462763
[TBL] [Abstract][Full Text] [Related]
17. Economic Burden of COPD in the Presence of Comorbidities.
Mannino DM; Higuchi K; Yu TC; Zhou H; Li Y; Tian H; Suh K
Chest; 2015 Jul; 148(1):138-150. PubMed ID: 25675282
[TBL] [Abstract][Full Text] [Related]
18. COPD prevalence in smokers with stable ischemic heart disease: A cross-sectional study in Tunisia.
Yangui F; Touil A; Antit S; Zakhama L; Charfi MR
Respir Med; 2021 Apr; 179():106335. PubMed ID: 33621707
[TBL] [Abstract][Full Text] [Related]
19. The health care burden of high grade chronic obstructive pulmonary disease in Korea: analysis of the Korean Health Insurance Review and Assessment Service data.
Kim J; Rhee CK; Yoo KH; Kim YS; Lee SW; Park YB; Lee JH; Oh Y; Lee SD; Kim Y; Kim K; Yoon H
Int J Chron Obstruct Pulmon Dis; 2013; 8():561-8. PubMed ID: 24277985
[TBL] [Abstract][Full Text] [Related]
20. Direct medical costs of ADHD and its comorbid conditions on basis of a claims data analysis.
Libutzki B; Ludwig S; May M; Jacobsen RH; Reif A; Hartman CA
Eur Psychiatry; 2019 May; 58():38-44. PubMed ID: 30802682
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
